Elon Musk, touted that he has reaped the benefits of a controversial class of weight-loss drugs, after fellow top Trump adviser, Robert F. Kennedy Jr., said the trendy new class of drugs is bad ...

FDA faces radical changes under Trump, risking public health and regulatory stability. • Trump reinstates the “Schedule F” order, threatening federal employees’ job security and increasing political ...

RFK Jr. is declaring war on chronic illness, which, if he succeeds, will not only make us healthier but will also cut down ...

Robert F. Kennedy Jr., Donald Trump’s nominee to run the Department of Health and Human Services, once pitched the idea to ...

Several nominees face critical tests in the U.S. Senate before President-elect Donald Trump returns to the White House on ...

Robert F. Kennedy Jr. has built his fortune and reputation on disparaging the government scientists and institutions he's now ...

Kennedy is facing a predictably skeptical reception from both sides of the polis he pursues a bid to become HHS Secretary ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity. Elon Musk spent over a quarter of ...

Robert F. Kennedy Jr., President Trump’s nominee for health secretary, doesn’t just hold fringe views on vaccines. We fact-checked five recent statements.

Statements by Robert F. Kennedy Jr. and Elon Musk tap into a dispute over whether lifestyle changes or drugs are a better way to treat obesity. President-elect Donald Trump’s choice for health ...